Ensign Peak Advisors’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $460K | Hold |
|
|||||
|
2025
Q1 | $1.72M | Sell |
|
|||||
|
2024
Q4 | $21.1M | Sell |
|
|||||
|
2024
Q3 | $28.1M | Hold |
|
|||||
|
2024
Q2 | $35.6M | Buy |
|
|||||
|
2024
Q1 | $24.2M | Sell |
|
|||||
|
2023
Q4 | $18.7M | Sell |
|
|||||
|
2023
Q3 | $24M | Sell |
|
|||||
|
2023
Q2 | $22.7M | Buy |
|
|||||
|
2023
Q1 | $25.8M | Buy |
|
|||||
|
2022
Q4 | $19.1M | Buy |
|
|||||
|
2022
Q3 | $14.4M | Buy |
|
|||||
|
2022
Q2 | $1.54M | Buy |
|
|||||
|
2022
Q1 | $1.57M | Hold |
|
|||||
|
2021
Q4 | $1.81M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $3.88M | Sell |
|
|||||
|
2020
Q3 | $4.14M | Buy |
|
|||||
|
2020
Q2 | $1.06M | Buy |
|
|||||
|
2020
Q1 | $162K | Sell |
|
|||||
|
2019
Q4 | $362K | Buy |
|